ACKR3

ACKR3
Available structures PDB Ortholog search: PDBe RCSB List of PDB id codes 7SK6, 7SK5
Identifiers
Aliases	ACKR3, CMKOR1, CXC-R7, CXCR-7, CXCR7, GPR159, RDC-1, RDC1, atypical chemokine receptor 3
External IDs	OMIM: 610376; MGI: 109562; HomoloGene: 22419; GeneCards: ACKR3; OMA:ACKR3 - orthologs
Gene location (Human) Chr. Chromosome 2 (human) Band 2q37.3 Start 236,567,787 bp End 236,582,354 bp
Gene location (Mouse) Chr. Chromosome 1 (mouse) Band 1 D|1 45.28 cM Start 90,131,702 bp End 90,144,473 bp
RNA expression pattern Bgee Human Mouse (ortholog) Top expressed in synovial joint vena cava tendon of biceps brachii cartilage tissue skin of hip saphenous vein pericardium synovial membrane tibial arteries mucosa of paranasal sinus Top expressed in medial ganglionic eminence renal corpuscle medullary collecting duct endocardial cushion aortic valve stria vascularis ascending aorta ciliary body myocardium of ventricle iris More reference expression data BioGPS More reference expression data
Gene ontology Molecular function C-X-C chemokine receptor activity G protein-coupled receptor activity coreceptor activity C-X-C chemokine binding signal transducer activity chemokine binding scavenger receptor activity protein binding C-C chemokine receptor activity C-C chemokine binding Cellular component cytoplasm integral component of membrane recycling endosome endosome intracellular membrane-bounded organelle membrane plasma membrane cell surface early endosome perinuclear region of cytoplasm clathrin-coated pit nucleus external side of plasma membrane Biological process chemokine-mediated signaling pathway receptor internalization negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage vasculogenesis multicellular organism development chemotaxis cell adhesion angiogenesis positive regulation of ERK1 and ERK2 cascade viral process signal transduction positive regulation of mesenchymal stem cell migration G protein-coupled receptor signaling pathway immune response positive regulation of cytosolic calcium ion concentration calcium-mediated signaling cell chemotaxis Sources:Amigo / QuickGO
Orthologs Species Human Mouse Entrez 57007 12778 Ensembl ENSG00000144476 ENSMUSG00000044337 UniProt P25106 P56485 RefSeq (mRNA) NM_001047841 NM_020311 NM_001271607 NM_007722 RefSeq (protein) NP_064707 NP_001258536 NP_031748 Location (UCSC) Chr 2: 236.57 – 236.58 Mb Chr 1: 90.13 – 90.14 Mb PubMed search
Wikidata
View/Edit Human View/Edit Mouse

Atypical chemokine receptor 3 also known as C-X-C chemokine receptor type 7 (CXCR-7) and G-protein coupled receptor 159 (GPR159) is a protein that in humans is encoded by the ACKR3 gene.

This gene encodes a member of the G protein-coupled receptor family. This protein was earlier thought to be a receptor for vasoactive intestinal peptide (VIP) and was considered to be an orphan receptor. It is now classified as a chemokine receptor able to bind the chemokines CXCL12/SDF-1 and CXCL11. The protein is also a coreceptor for human immunodeficiency viruses (HIV). Translocations involving this gene and HMGA2 on chromosome 12 have been observed in lipomas. Alternatively spliced transcript variants encoding the same protein isoform have been found for this gene. Whereas some reports claim that the receptor induces signaling following ligand binding, recent findings in zebrafish suggest that CXCR7 functions primarily by sequestering the chemokine CXCL12.

Another study has provided evidence that ligand binding to CXCR7 activates MAP kinases through Beta-arrestins, and thus has functions beyond ligand sequestration.

ACKR3 has also been shown to sequester endogenous opioid peptides, and is thought to modulate their activity. Inhibition of ACKR3 by ligands such as the peptide LIH383 (FGGFMRRK-NH₂) increases opioid peptide activity and produces analgesic and antidepressant effects in animal studies.

External links

• Human ACKR3 genome location and ACKR3 gene details page in the UCSC Genome Browser.

Further reading

• Nagata S, Ishihara T, Robberecht P, Libert F, Parmentier M, Christophe J, Vassart G (March 1992). "RDC1 may not be VIP receptor". Trends in Pharmacological Sciences. 13 (3): 102–3. doi:10.1016/0165-6147(92)90037-7. PMID 1315461.
• Libert F, Passage E, Parmentier M, Simons MJ, Vassart G, Mattei MG (September 1991). "Chromosomal mapping of A1 and A2 adenosine receptors, VIP receptor, and a new subtype of serotonin receptor". Genomics. 11 (1): 225–7. doi:10.1016/0888-7543(91)90125-X. PMID 1662665.
• Sreedharan SP, Robichon A, Peterson KE, Goetzl EJ (June 1991). "Cloning and expression of the human vasoactive intestinal peptide receptor". Proceedings of the National Academy of Sciences of the United States of America. 88 (11): 4986–90. doi:10.1073/pnas.88.11.4986. PMC 51792. PMID 1675791.
• Law NM, Rosenzweig SA (May 1994). "Characterization of the G-protein linked orphan receptor GPRN1/RDC1". Biochemical and Biophysical Research Communications. 201 (1): 458–65. doi:10.1006/bbrc.1994.1723. PMID 8198609.
• Shimizu N, Soda Y, Kanbe K, Liu HY, Mukai R, Kitamura T, Hoshino H (January 2000). "A putative G protein-coupled receptor, RDC1, is a novel coreceptor for human and simian immunodeficiency viruses". Journal of Virology. 74 (2): 619–26. doi:10.1128/JVI.74.2.619-626.2000. PMC 111581. PMID 10623723.
• Broberg K, Zhang M, Strömbeck B, Isaksson M, Nilsson M, Mertens F, Mandahl N, Panagopoulos I (August 2002). "Fusion of RDC1 with HMGA2 in lipomas as the result of chromosome aberrations involving 2q35-37 and 12q13-15". International Journal of Oncology. 21 (2): 321–6. doi:10.3892/ijo.21.2.321. PMID 12118328.
• Infantino S, Moepps B, Thelen M (February 2006). "Expression and regulation of the orphan receptor RDC1 and its putative ligand in human dendritic and B cells". Journal of Immunology. 176 (4): 2197–207. doi:10.4049/jimmunol.176.4.2197. PMID 16455976.
• Burns JM, Summers BC, Wang Y, Melikian A, Berahovich R, Miao Z, Penfold ME, Sunshine MJ, Littman DR, Kuo CJ, Wei K, McMaster BE, Wright K, Howard MC, Schall TJ (September 2006). "A novel chemokine receptor for SDF-1 and I-TAC involved in cell survival, cell adhesion, and tumor development". The Journal of Experimental Medicine. 203 (9): 2201–13. doi:10.1084/jem.20052144. PMC 2118398. PMID 16940167.
• Proost P, Mortier A, Loos T, Vandercappellen J, Gouwy M, Ronsse I, Schutyser E, Put W, Parmentier M, Struyf S, Van Damme J (July 2007). "Proteolytic processing of CXCL11 by CD13/aminopeptidase N impairs CXCR3 and CXCR7 binding and signaling and reduces lymphocyte and endothelial cell migration". Blood. 110 (1): 37–44. doi:10.1182/blood-2006-10-049072. PMID 17363734.
• Miao Z, Luker KE, Summers BC, Berahovich R, Bhojani MS, Rehemtulla A, Kleer CG, Essner JJ, Nasevicius A, Luker GD, Howard MC, Schall TJ (October 2007). "CXCR7 (RDC1) promotes breast and lung tumor growth in vivo and is expressed on tumor-associated vasculature". Proceedings of the National Academy of Sciences of the United States of America. 104 (40): 15735–40. doi:10.1073/pnas.0610444104. PMC 1994579. PMID 17898181.
• Wang J, Shiozawa Y, Wang J, Wang Y, Jung Y, Pienta KJ, Mehra R, Loberg R, Taichman RS (February 2008). "The role of CXCR7/RDC1 as a chemokine receptor for CXCL12/SDF-1 in prostate cancer". The Journal of Biological Chemistry. 283 (7): 4283–94. doi:10.1074/jbc.M707465200. PMID 18057003.
• Boldajipour B, Mahabaleshwar H, Kardash E, Reichman-Fried M, Blaser H, Minina S, Wilson D, Xu Q, Raz E (February 2008). "Control of chemokine-guided cell migration by ligand sequestration". Cell. 132 (3): 463–73. doi:10.1016/j.cell.2007.12.034. PMID 18267076.

This article incorporates text from the United States National Library of Medicine, which is in the public domain.